Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed
Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed

Explore GLP-1's
News & Updates

Learn more about GLP'-1's latest news & updates

Explore By Category

All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
GLP-1 Social Stigma: What Users Face and How to Handle It
Patient Guides

GLP-1 Social Stigma: What Users Face and How to Handle It

A Florida State University researcher has found that people using GLP-1 medications like semaglutide and tirzepatide often face unexpected stigma from their own social circles. This article breaks down why that stigma happens, how it affects treatment outcomes, and what you can do to protect your mental health while staying on track with your medication.

Read More
Generic Ozempic Shortage: What Patients Need to Know
News & Updates

Generic Ozempic Shortage: What Patients Need to Know

Generic semaglutide (the biosimilar version of Ozempic) is running out at pharmacies across Quebec due to recalls and surging demand. If you're currently on this medication or planning to start, here's what the shortage means for your treatment and what alternatives exist.

Read More
GLP-1 Lawsuits Over Vision Loss: What Patients Need to Know
Side Effects & Safety

GLP-1 Lawsuits Over Vision Loss: What Patients Need to Know

Lawsuits are emerging against GLP-1 drug manufacturers over reported cases of vision loss in some patients. This article breaks down what the legal claims involve, what the medical research currently shows, and what questions you should ask your doctor before or during treatment.

Read More
Wegovy Approved for Liver Disease in Singapore
News & Updates

Wegovy Approved for Liver Disease in Singapore

Singapore has approved Wegovy (semaglutide) as the first medication specifically indicated for MASH with liver fibrosis, a serious liver condition affecting millions globally. This expands the growing body of evidence that GLP-1 medications do far more than help with weight loss. Here is what patients and those considering GLP-1 therapy need to know.

Read More
Medicare GLP-1 Coverage: What 700K Seniors Mean for You
News & Updates

Medicare GLP-1 Coverage: What 700K Seniors Mean for You

Medicare's GLP-1 coverage program has reached 700,000 seniors, with Eli Lilly capturing roughly 70% of that market. This milestone signals a major shift in how older Americans access weight loss and diabetes medications, but navigating the coverage details still takes work.

Read More
Judd Apatow Gained Weight on Ozempic: Here's Why That Can Happen
News & Updates

Judd Apatow Gained Weight on Ozempic: Here's Why That Can Happen

On Jimmy Kimmel Live! in August 2026, Leslie Mann said her husband, director Judd Apatow, has gained about 15 pounds in four years on the highest dose of Ozempic because he likes to override the fullness it creates. His story is a clear example of how GLP-1 medications work and where their limits are.

Read More
FDA Approves Mounjaro to Reduce Heart Risk in Type 2 Diabetes
News & Updates

FDA Approves Mounjaro to Reduce Heart Risk in Type 2 Diabetes

On August 28, 2026, the FDA approved Mounjaro (tirzepatide) to lower the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes who are at high cardiovascular risk. The approval rests on SURPASS CVOT, which compared Mounjaro head to head with Trulicity. It does not extend to people with obesity who do not have diabetes.

Read More
Best Supplements to Take With GLP-1 Medications
Nutrition & Diet

Best Supplements to Take With GLP-1 Medications

GLP-1 medications like semaglutide and tirzepatide cut appetite substantially, which can open nutritional gaps over time. A few targeted supplements may help protect muscle and prevent deficiencies that often go unnoticed. Here is what the evidence says and what to discuss with your doctor.

Read More
Combination Therapy: What Comes After GLP-1 Drugs?
Science & How It Works

Combination Therapy: What Comes After GLP-1 Drugs?

Combination obesity drugs that target several hormone pathways at once are moving from trials toward approval. Retatrutide posted 28.3% average weight loss in Phase 3, and CagriSema is under FDA review. Here is what that means for patients on GLP-1 therapy now.

Read More